Abstract

In this case report, we present a pregnant woman diagnosed with COVID-19 at 33 weeks gestation and having a vaginal birth at term. The postpartum and neonatal courses were uncomplicated. Anti-SARS-CoV-2-IgG antibodies were detected in the neonate. A vaginal delivery in this case was safe with clinical diagnosis of COVID-19.

Highlights

  • To date, there are only limited data about the effect of novel coronavirus (SARS-CoV-2) infection on pregnancy, delivery and placental transfer of antibodies

  • We present a pregnant woman diagnosed with COVID-19 at 33 weeks gestation and having a vaginal birth at term

  • We report a pregnant woman in her 33 weeks gestation diagnosed with COVID-19 by PCR and serology, who delivered a healthy, but Anti-SARS-CoV2-IgG-positive infant

Read more

Summary

Introduction

There are only limited data about the effect of novel coronavirus (SARS-CoV-2) infection on pregnancy, delivery and placental transfer of antibodies. We present a pregnant woman diagnosed with COVID-19 at 33 weeks gestation and having a vaginal birth at term. Anti-SARS-CoV-2-IgG antibodies were detected in the neonate. A vaginal delivery in this case was safe with clinical diagnosis of COVID-19.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call